BioLight Life Sciences Ltd. (TLV:BOLT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
557.00
-0.90 (-0.16%)
May 7, 2025, 10:15 AM IDT
25.08%
Market Cap 26.15M
Revenue (ttm) 219.00K
Net Income (ttm) -7.14M
Shares Out 4.69M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 84
Average Volume 898
Open 557.00
Previous Close 557.90
Day's Range 557.00 - 557.00
52-Week Range 4.40 - 702.00
Beta 0.25
RSI 20.21
Earnings Date May 21, 2025

About BioLight Life Sciences

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company’s ophthalmic product offering and pipeline of product candidates include DiagnosTear’s TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival imp... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BOLT
Full Company Profile

Financial Performance

In 2024, BioLight Life Sciences's revenue was 219,000, an increase of 85.59% compared to the previous year's 118,000. Losses were -7.14 million, -72.55% less than in 2023.

Financial Statements

News

There is no news available yet.